Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
about
Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFPI3K/PTEN/AKT signaling regulates prostate tumor angiogenesisGentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitorsDevelopment of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding siteActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptorCharacterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growthMechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factorRegulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alphaCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryMacrophage migration inhibitory factor promotes colorectal cancerExpression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumoursEffects of visual experience on vascular endothelial growth factor expression during the postnatal development of the rat visual cortexIdentification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activityA novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular developmentVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisGuanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseasesVanadate-induced expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen speciesMolecular responses to hypoxia in tumor cellsPathways for aberrant angiogenesis in pancreatic cancerCap-Independent Translational Control of CarcinogenesisThe Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic ReviewMechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiformeBrain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mindAntibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsDynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel densityVascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like CellsStress responses from the endoplasmic reticulum in cancerAdaptation to antiangiogenic therapy in neurological tumorsMatrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growthSelective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastomaVascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cellsA heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placentaHypoxia and VEGF mRNA expression in human tumorsVEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanismPTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administrationReactive oxygen species a double-edged sword for mesotheliomaQuercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cellsCharacterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization.
P2860
Q22253478-F4B3F42A-4F9C-4ED5-92D8-BFFDBD094876Q23914949-EFD40F52-E20A-429E-80EB-E9C1398AEAC2Q24298832-16A9FB99-8A34-4A1B-84E1-95795F55DBE0Q24302190-2C4C2E9D-2A3D-422A-8F47-A7B14BBA448CQ24316075-6D387521-AD11-4B15-AF72-9247BB486862Q24320710-8609C5FA-3CE5-4266-B79D-06878F337473Q24561921-C7FD193C-BAAD-44FD-B6D3-0434CB59DDF5Q24561970-887B2F39-F03F-4F05-A6A3-A14A04C48247Q24610199-D71F5199-335D-46FA-8D16-9C668FD74F96Q24630927-9CF12931-1BB3-45E4-B108-7E5480DB320FQ24642663-97CB8F7A-CF77-4651-AA0D-00622F21FBDEQ24651722-FE131957-A3C5-4F8F-8B2C-B1591644615EQ24654119-04B0388F-2D4E-47E8-8068-6E9E90448FEFQ24677555-F9E328B8-0BF4-455E-A7A5-6441CD45D832Q24681396-E96D850E-E35F-434D-80E3-45D2D0A1B924Q24684263-D5945F47-C7D9-46C4-B5DB-3B577771E99AQ24685277-60425598-5B29-4C47-A83C-6DC865521697Q24720804-2E1E1405-ABF1-4D8C-A598-A49E71E20C3EQ24797310-D19E359C-0F88-4E3F-8DAA-821B13C4DF7CQ24800215-03D802DE-FB15-481A-91CB-1C1E7624A001Q26744030-097D3B14-A916-4408-97F8-6A960A0A7905Q26752321-C39076DC-EC14-460F-A066-E5FC23AAF854Q26824557-3BF71B65-9764-4081-B9E8-942A9AA87AEBQ26826870-8DF7697E-BCA4-4881-9AEB-7F679573B3E2Q27011298-60FDE961-9CF7-4483-A6CA-F183248A7172Q27308856-2BCEA88F-9DB3-4457-B427-F14F15E69E47Q28072067-3ACBC14B-AF54-40F9-9C9E-E35DCA5E988FQ28082709-60FAA606-FB33-4271-BE93-BCD9A5C92CD7Q28082908-61146DA0-D847-4CBB-A5B2-DFAD483DABC8Q28214421-8865FADF-25B3-4199-9218-6A8834F00411Q28216536-3DDA4FAD-7C78-4111-90C4-10213F9DD62DQ28216873-704EE31B-A7DB-47FE-A515-9A34DB415D84Q28240564-D90E8813-9A8D-4E22-84D2-C8A48DE03849Q28251626-AEE5EA07-E902-48ED-BA45-5A7E5BB0E9F8Q28344471-31A132F5-A298-48B5-9FF8-E23B8281DDC9Q28375509-61A4E8D4-8A19-40B1-B20D-B31AB10CA46BQ28378001-72FC63BE-A5B1-4E51-849D-4A3DBAF568BCQ28392665-54D21FE8-085A-4DD9-BD28-860470F0F3BBQ28480617-977069E5-E7DF-4F23-901A-53BFE7F38BC7Q28504628-7396D7FD-3CE8-416D-96D5-09D40CBF8BBD
P2860
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... ctor in human gliomas in vivo.
@en
Vascular endothelial growth fa ...... ctor in human gliomas in vivo.
@nl
type
label
Vascular endothelial growth fa ...... ctor in human gliomas in vivo.
@en
Vascular endothelial growth fa ...... ctor in human gliomas in vivo.
@nl
prefLabel
Vascular endothelial growth fa ...... ctor in human gliomas in vivo.
@en
Vascular endothelial growth fa ...... ctor in human gliomas in vivo.
@nl
P2093
P356
P1433
P1476
Vascular endothelial growth fa ...... actor in human gliomas in vivo
@en
P2093
P2888
P304
P356
10.1038/359845A0
P407
P50
P577
1992-10-01T00:00:00Z
P6179
1021927273